Version history

{
  "session_id": "sess-hyp-8a90163989de",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "llm",
  "action": "propose",
  "content": "\n\n# Systematic Evaluation of Closed-Loop tFUS Targeting SST Interneurons for Gamma Restoration in AD\n\n## Mechanistic Rationale Analysis\n\n### 1. Foundational Circuit Logic\n\nThe hypothesis presents a coherent circuit mechanism with the following logical structure:\n\n**Pathogenic cascade:**\n- Aβ preferentially targets PV+ interneurons (well-documented)\n- Loss of PV inhibition → disinhibition of excitatory networks → hyperexcitability\n- Compensatory SST interneuron hyperactivity emerges as homeostatic response\n- Excess SST output creates dual inhibition on: (a) pyramidal cell dendrites, (b) surviving PV interneurons\n- This creates a **vicious cycle** where remaining PV cells cannot generate gamma\n\n**Therapeutic logic:**\n- Reducing SST activity → removes inhibition from PV cells (\"disinhibition\")\n- PV disinhibition → restores gamma generation capability\n- Restored gamma → improves memory encoding and potentially clears Aβ\n\nThe mechanistic rationale is **plausible but requires qualification**. The concept of \"indirect disinhibition\" through SST modulation is consistent with known hippocampal microcircuitry—the SST+ O-LM interneurons do form inhibitory synapses onto PV+ basket cells in the stratum oriens-alveus border (J. physiol. 2018; 596:3745). However, the directionality of the proposed modulation (inhibition of SST neurons, not excitation) distinguishes this from standard disinhibition architectures and represents a novel therapeutic angle.\n\n### 2. Gene/Target Validity: SST\n\n**Evidence supporting SST as disease-relevant:**\n\n| Finding | Source/Context |\n|---------|----------------|\n| SST expression declines with AD progression | Human postmortem hippocampal tissue (AD cases show 30-50%",
  "tokens_used": "427",
  "persona_id": "persona-theorist"
}